Stantec Inc. (TSE:STN – Get Rating) (NYSE:STN) shares crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of C$67.23 and traded as high as C$79.24. Stantec shares last traded at C$78.95, with a volume of 386,064 shares trading hands.
Analyst Upgrades and Downgrades
Several research firms have issued reports on STN. Raymond James upped their target price on shares of Stantec from C$80.00 to C$90.00 and gave the company a “strong-buy” rating in a research note on Thursday, January 26th. TD Securities upped their target price on shares of Stantec from C$79.00 to C$93.00 and gave the company a “buy” rating in a research note on Friday, February 24th. BMO Capital Markets upped their target price on shares of Stantec from C$76.00 to C$86.00 in a research note on Friday, February 24th. National Bankshares upped their price target on shares of Stantec from C$78.00 to C$89.00 in a research report on Friday, February 24th. Finally, ATB Capital upped their price target on shares of Stantec from C$75.00 to C$85.00 in a research report on Friday, February 24th. Five analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Buy” and an average target price of C$86.56.
Stantec Stock Up 0.3 %
The company’s 50-day moving average price is C$72.22 and its 200 day moving average price is C$67.23. The stock has a market cap of C$8.75 billion, a PE ratio of 35.25, a price-to-earnings-growth ratio of 1.46 and a beta of 0.78. The company has a debt-to-equity ratio of 84.09, a quick ratio of 1.46 and a current ratio of 1.37.
Stantec Increases Dividend
About Stantec
Stantec Inc provides engineering, architecture, and environmental consulting services in the areas of infrastructure and facilities in Canada, the United States, and internationally. The company provides consulting services in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics.
Featured Stories
- Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
- GitLab Crashes On Guidance; Analysts DefendĀ
- Healthcare Stocks With at Least 30 Years of Dividend Increases
- Coinbase Pops As SVB Crumbles To Dust
- Airlines Update Guidance, Shares Head For Different Destinations
Receive News & Ratings for Stantec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stantec and related companies with MarketBeat.com's FREE daily email newsletter.